Factors affecting the bioavailability of phenytoin.


The bioavailability of seven phenytoin (DPH) formulations, five brands of tablets and two suspensions, was measured in a cross-over study with six healthy volunteers. Single doses of 600 mg of DPH were used and the bioavailability was determined as the area under the serum DPH concentration-time curve (AUC). Highly significant differences between the… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.